文章：

早期肝细胞癌的经皮局部治疗：东西方观点

Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives

原文发布日期：6 August 2023

DOI: 10.3390/cancers15153988

类型: Review

开放获取: 是

英文摘要：

Hepatocellular carcinoma represents an important cause of death worldwide. Early-stage hepatocellular carcinoma patients not suitable for surgery can be treated with a variety of minimally invasive locoregional interventional oncology techniques. Various guidelines in different countries address the treatment of hepatocellular carcinoma, but the actual treatment is usually discussed by a multidisciplinary tumor board in a personalized manner, leading to potential treatment differences based on Western and Eastern perspectives. The aim of this paper is to integrate literature evidence with the eminent experiences collected during a focused session at the Mediterranean Interventional Oncology (MIO) Live Congress 2023.

摘要翻译： 

肝细胞癌是全球重要的死亡原因之一。不适合手术的早期肝细胞癌患者可以采用多种微创局部区域介入肿瘤学技术进行治疗。不同国家的各种指南涉及肝细胞癌的治疗，但实际治疗通常由多学科肿瘤委员会以个性化的方式讨论决定，这可能导致基于西方和东方观点的潜在治疗差异。本文的目的是将文献证据与2023年地中海介入肿瘤学（MIO）现场大会期间收集的杰出经验相结合。

原文链接：

Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives